Vectus Biosystems progresses its human trials with lead cardiovascular drug candidate VB0004
October 23, 2022
0ASX:VBS
Watch the video above for detailed insights and analysis.
Video Details
Featured Companies: ASX:VBS
Recorded: October 23, 2022
Stay Ahead
Get the latest market insights and analysis delivered to your inbox.